Literature DB >> 22045828

Cancer incidence in patients with schizophrenia or bipolar disorder: a nationwide population-based study in Taiwan, 1997-2009.

Gen-Min Lin1, Yu-Jung Chen, De-Jhen Kuo, Lamin E S Jaiteh, Yi-Chung Wu, Tzu-Shun Lo, Yi-Hwei Li.   

Abstract

BACKGROUND: Both genetic and environmental factors have been reasoned for cancer development in schizophrenia patients. However, the influence of age of onset and duration of schizophrenia on cancer incidence has rarely been emphasized. Besides, bipolar disorder tends to resemble schizophrenia from the perspective of multiple rare mutations. Comparing pattern and risk of cancers between schizophrenia and bipolar patients is illuminating.
METHODS: This study used the Taiwan National Health Insurance Database. A total of 71,317 schizophrenia and 20,567 bipolar disorder patients from 1997 to 2009 were enrolled. Both cohorts were followed up for cancer during the same period by record linkage with the cancer certification in Taiwan. Age and gender standardized incidence ratios (SIRs) of overall and site-specific cancers were calculated.
RESULTS: The SIR for all cancers was 1.17 for the schizophrenia cohort. Increased cancer risk (SIR: 1.31, 95% CI: 1.17-1.48) was observed in females but not males. For the bipolar disorder cohort, the SIR for all cancers was 1.29, but the excess risk was found in males (SIR: 1.42, 95% CI: 1.14-1.77) and not females. Cancer risk decreases as the duration and age of onset of schizophrenia increases. If schizophrenia is diagnosed before 50, the SIRs for colorectal, breast, cervical, and uterine cancers increase but if diagnosed after 50, the SIRs for all cancers decrease except for breast cancer. In bipolar disorder, the SIRs for all site-specific cancers were insignificant.
CONCLUSIONS: Among schizophrenia patients, overall cancer risk varies inversely with age at diagnosis and disease duration. Besides, gender-specific cancer risks differ between schizophrenia and bipolar disorder.

Entities:  

Mesh:

Year:  2011        PMID: 22045828      PMCID: PMC3576164          DOI: 10.1093/schbul/sbr162

Source DB:  PubMed          Journal:  Schizophr Bull        ISSN: 0586-7614            Impact factor:   9.306


  39 in total

1.  Immunological aspects in the neurobiology of suicide: elevated microglial density in schizophrenia and depression is associated with suicide.

Authors:  Johann Steiner; Hendrik Bielau; Ralf Brisch; Peter Danos; Oliver Ullrich; Christian Mawrin; Hans-Gert Bernstein; Bernhard Bogerts
Journal:  J Psychiatr Res       Date:  2006-12-15       Impact factor: 4.791

2.  The incidence of cancer in schizophrenic patients.

Authors:  P B Mortensen
Journal:  J Epidemiol Community Health       Date:  1989-03       Impact factor: 3.710

Review 3.  Scenarios for a viral etiology of schizophrenia.

Authors:  C B Pert; J G Knight; P Laing; M A Markwell
Journal:  Schizophr Bull       Date:  1988       Impact factor: 9.306

4.  Incidence of cancer among persons with schizophrenia and their relatives.

Authors:  D Lichtermann; J Ekelund; E Pukkala; A Tanskanen; J Lönnqvist
Journal:  Arch Gen Psychiatry       Date:  2001-06

Review 5.  Prolactin and breast cancer risk.

Authors:  Shelley S Tworoger; Susan E Hankinson
Journal:  Cancer Lett       Date:  2006-03-10       Impact factor: 8.679

6.  Increased levels of serum basic fibroblast growth factor in schizophrenia.

Authors:  Kenji Hashimoto; Eiji Shimizu; Naoya Komatsu; Michiko Nakazato; Naoe Okamura; Hiroyuki Watanabe; Chikara Kumakiri; Naoyuki Shinoda; Shin-ichi Okada; Nori Takei; Masaomi Iyo
Journal:  Psychiatry Res       Date:  2003-10-15       Impact factor: 3.222

7.  Nondementia nonpraecox dementia praecox? Late-onset schizophrenia.

Authors:  D V Jeste; L L Symonds; M J Harris; J S Paulsen; B W Palmer; R K Heaton
Journal:  Am J Geriatr Psychiatry       Date:  1997       Impact factor: 4.105

8.  Specific localisation of human cytomegalovirus nucleic acids and proteins in human colorectal cancer.

Authors:  Lualhati Harkins; Andrea L Volk; Minu Samanta; Ivan Mikolaenko; William J Britt; Kirby I Bland; Charles S Cobbs
Journal:  Lancet       Date:  2002-11-16       Impact factor: 79.321

Review 9.  Cytokines and other immunological biomarkers in children's environmental health studies.

Authors:  Paurene Duramad; Ira B Tager; Nina T Holland
Journal:  Toxicol Lett       Date:  2007-05-25       Impact factor: 4.372

Review 10.  Theories of schizophrenia: a genetic-inflammatory-vascular synthesis.

Authors:  Daniel R Hanson; Irving I Gottesman
Journal:  BMC Med Genet       Date:  2005-02-11       Impact factor: 2.103

View more
  26 in total

Review 1.  Medical Comorbidities in Bipolar Disorder.

Authors:  Aktriti Sinha; Anam Shariq; Khaled Said; Abhinav Sharma; D Jeffrey Newport; Ihsan M Salloum
Journal:  Curr Psychiatry Rep       Date:  2018-05-07       Impact factor: 5.285

Review 2.  Inflammation and the two-hit hypothesis of schizophrenia.

Authors:  Keith A Feigenson; Alex W Kusnecov; Steven M Silverstein
Journal:  Neurosci Biobehav Rev       Date:  2013-11-15       Impact factor: 8.989

3.  Oxidatively-induced DNA damage and base excision repair in euthymic patients with bipolar disorder.

Authors:  Deniz Ceylan; Gamze Tuna; Güldal Kirkali; Zeliha Tunca; Güneş Can; Hidayet Ece Arat; Melis Kant; Miral Dizdaroglu; Ayşegül Özerdem
Journal:  DNA Repair (Amst)       Date:  2018-03-30

4.  Effects of antipsychotics, antidepressants and mood stabilizers on risk for physical diseases in people with schizophrenia, depression and bipolar disorder.

Authors:  Christoph U Correll; Johan Detraux; Jan De Lepeleire; Marc De Hert
Journal:  World Psychiatry       Date:  2015-06       Impact factor: 49.548

Review 5.  Inverse cancer comorbidity: a serendipitous opportunity to gain insight into CNS disorders.

Authors:  Rafael Tabarés-Seisdedos; John L Rubenstein
Journal:  Nat Rev Neurosci       Date:  2013-04       Impact factor: 34.870

6.  Cancer risk before schizophrenia diagnosis in Taiwan, 1995-2009.

Authors:  Yu-Jung Chen; Gen-Min Lin; Yi-Hwei Li
Journal:  Schizophr Bull       Date:  2013-05-02       Impact factor: 9.306

7.  Antipsychotic use is a risk factor for hyponatremia in patients with schizophrenia: a 15-year follow-up study.

Authors:  Hang-Ju Yang; Wan-Ju Cheng
Journal:  Psychopharmacology (Berl)       Date:  2017-01-11       Impact factor: 4.530

8.  Cancer incidence in young and middle-aged people with schizophrenia: nationwide cohort study in Taiwan, 2000-2010.

Authors:  L Y Chen; Y N Hung; Y Y Chen; S Y Yang; C H Pan; C C Chen; C J Kuo
Journal:  Epidemiol Psychiatr Sci       Date:  2016-11-21       Impact factor: 6.892

9.  Incidence of cancer in patients with schizophrenia and their first-degree relatives: a population-based study in Sweden.

Authors:  Jianguang Ji; Kristina Sundquist; Yi Ning; Kenneth S Kendler; Jan Sundquist; Xiangning Chen
Journal:  Schizophr Bull       Date:  2012-04-20       Impact factor: 9.306

10.  Cancer screening, prevention, and treatment in people with mental illness.

Authors:  Lara C Weinstein; Ana Stefancic; Amy T Cunningham; Katelyn E Hurley; Leopodo J Cabassa; Richard C Wender
Journal:  CA Cancer J Clin       Date:  2015-12-10       Impact factor: 508.702

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.